U.S. FDA Accepts New Drug Application Under Priority Review for Takeda’s Zasocitinib in Moderate-to-Severe Plaque Psoriasis, with Potential to Redefine Oral …

Takeda (TSE:4502/NYSE:TAK) announced that the U.S. Food and Drug Administration (FDA) accepted its New Drug Application (NDA) ...
Education Executive

Financial Literacy for Leaders – Who Needs to Know What?

School finance is everyone’s responsibility, not just the school business professional. Clare Skinner explains why all ...